16 Jun 2021 Commercial Agency Agreement between Ardena and South Korean company Keyfronbio Co., Ltd. Member news
15 Jun 2021 Biotalys announces intention to launch an Initial Public Offering on Euronext Brussels Member news
14 Jun 2021 Montis Biosciences awarded VLAIO grant to expand its pipeline of novel immune-oncology therapeutics Member news
14 Jun 2021 Precigen ActoBio announces positive topline results from Phase 1b/2a Study of AG019 ActoBiotics™ Member news
10 Jun 2021 OXURION confirms Institutional Review Board approval and submission of the Investigational New Drug Application to the FDA to start Phase 2 Study evaluating THR-687 for Diabetic Macular Edema (DME) Member news
08 Jun 2021 OXURION completes patient enrollment for Part A of Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
